Efficacy and Safety of BP1.4979 in Smoking Cessation
NCT01785147
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
219
Enrollment
OTHER
Sponsor class
Conditions
Tobacco Addiction
Interventions
DRUG:
BP1.4979
DRUG:
Placebo
Sponsor
Bioprojet